BioLife Corporate Profile
Financials
2019 Annual Revenue
$18.92 Billion
2019 Gross Profit
$13.71 Billion
2019 Annual Net Income
$985 Million
2019 Fiscal Year Revenue Growth
18.38%
2019 Number of Stores
120
Credit Rating
Leases guaranteed by Baxalta, Inc., which senior unsecured notes are Investment Grade BBB+
BioLife Corporate Profile
Baxalta is a bio-pharmaceutical company which was founded in 2015. That same year, Baxalta was acquired by Shire PLC (SHPGF), a biotechnology company focused on serving people with rare diseases and other specialized conditions worldwide. The company markets its products through wholesalers, distributors, and pharmacies.